Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13354
Country/Region: Kenya
Year: 2014
Main Partner: Kenya Episcopal Conference
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $7,291,386 Additional Pipeline Funding: $61,750

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Kenya Episcopal Conference – Kenya AIDS Response Program (KEC-KARP) REDACTED is a local organization program implemented through Kenya Conference of Catholic Bishops. It supports HIV prevention, care and treatment services in 58 FBO health facilities in Western Kenya. The projects goals are aligned with the GHI principles and include support for country-led plans, collaboration with the Ministry of Health and Faith Based Organization’s HIV strategy, implementation of evidence-driven programs, and integration of HIV services in maternal and child health and TB clinics.

KEC’s goal is to reduce HIV-related morbidity and mortality through provision of comprehensive, high quality HIV services at faith-based facilities and affiliated sites. The target populations include pregnant women, adult and pediatric patients and TB patients.

Strategies to reduce cost will include regular business management system reviews, expenditure analysis, support for government and faith based organization-led programs to avoid duplication, collaboration with the county governments to support HIV services in FBO facilities, use of modular cost-effective facility-based trainings (recommended by the Ministry of Health), and support for an integrated mentorship program in order to capacity build facility teams.

Monitoring and evaluation for planned activities will be conducted on a monthly and quarterly basis and the feedback provided to the health care workers (HCW). Standard data summary charts will be provided to facilities and the HCW will track the same to monitor improvement. Supporting Electronic Medical Registers for patient monitoring, cohort analysis, Continuous Quality Improvement and regular program reviews will continue.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $231,408
Care: TB/HIV (HVTB) $250,428
Care: Pediatric Care and Support (PDCS) $78,066
Testing: HIV Testing and Counseling (HVCT) $279,657
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $449,887
Treatment: Adult Treatment (HTXS) $5,753,295
Treatment: Pediatric Treatment (PDTX) $248,645
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 5,046
C2.1.D By Age: 15+ 2015 50,885
C2.1.D By Age/Sex: <15 Female 2015 2,523
C2.1.D By Age/Sex: <15 Male 2015 2,523
C2.1.D By Age/Sex: 15+ Female 2015 33,584
C2.1.D By Age/Sex: 15+ Male 2015 17,301
C2.1.D By Sex: Female 2015 36,107
C2.1.D By Sex: Male 2015 19,824
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 55,931
C2.1.D Sum of Age disaggregates 2015 55,931
C2.1.D Sum of Age/Sex disaggregates 2015 55,931
C2.1.D Sum of Sex disaggregates 2015 55,931
C2.1.D_NGI By Age: <15 2015 5,046
C2.1.D_NGI By Age: 15+ 2015 50,885
C2.1.D_NGI By Age/Sex: <15 Female 2015 2,523
C2.1.D_NGI By Age/Sex: <15 Male 2015 2,523
C2.1.D_NGI By Age/Sex: 15+ Female 2015 33,584
C2.1.D_NGI By Age/Sex: 15+ Male 2015 17,301
C2.1.D_NGI By Sex: Female 2015 36,107
C2.1.D_NGI By Sex: Male 2015 19,824
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 55,931
C2.1.D_NGI Sum of Age disaggregates 2015 55,931
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 55,931
C2.1.D_NGI Sum of Sex disaggregates 2015 55,931
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 55,931
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 53,135
C2.5.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 55,931
C2.5.D Number of HIV-positive patients in HIV care who started TB treatment 2015 1,063
CARE_CURR Age/sex: <1 Female 2015 83
CARE_CURR Age/sex: <1 Male 2015 83
CARE_CURR Age/sex: 1-4 Female 2015 576
CARE_CURR Age/sex: 1-4 Male 2015 576
CARE_CURR Age/sex: 10-14 Female 2015 765
CARE_CURR Age/sex: 10-14 Male 2015 765
CARE_CURR Age/sex: 15-19 Female 2015 673
CARE_CURR Age/sex: 15-19 Male 2015 408
CARE_CURR Age/sex: 20-24 Female 2015 2,793
CARE_CURR Age/sex: 20-24 Male 2015 755
CARE_CURR Age/sex: 25-49 Female 2015 23,854
CARE_CURR Age/sex: 25-49 Male 2015 11,351
CARE_CURR Age/sex: 5-9 Female 2015 973
CARE_CURR Age/sex: 5-9 Male 2015 973
CARE_CURR Age/sex: 50+ Female 2015 4,585
CARE_CURR Age/sex: 50+ Male 2015 3,922
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 2,397
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 2,397
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 31,905
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 16,436
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 53,135
CARE_CURR Sum of Age/Sex disaggregates 2015 53,135
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 53,135
CARE_NEW Age/sex: <1 Female 2015 15
CARE_NEW Age/sex: <1 Male 2015 15
CARE_NEW Age/sex: 1-4 Female 2015 99
CARE_NEW Age/sex: 1-4 Male 2015 105
CARE_NEW Age/sex: 10-14 Female 2015 139
CARE_NEW Age/sex: 10-14 Male 2015 139
CARE_NEW Age/sex: 15-19 Female 2015 144
CARE_NEW Age/sex: 15-19 Male 2015 63
CARE_NEW Age/sex: 20-24 Female 2015 267
CARE_NEW Age/sex: 20-24 Male 2015 262
CARE_NEW Age/sex: 25-49 Female 2015 4,006
CARE_NEW Age/sex: 25-49 Male 2015 2,234
CARE_NEW Age/sex: 5-9 Female 2015 183
CARE_NEW Age/sex: 5-9 Male 2015 177
CARE_NEW Age/sex: 50+ Female 2015 1,383
CARE_NEW Age/sex: 50+ Male 2015 430
CARE_NEW Aggregated Age/sex: <15 Female 2015 436
CARE_NEW Aggregated Age/sex: <15 Male 2015 436
CARE_NEW Aggregated Age/sex: 15+ Female 2015 5,800
CARE_NEW Aggregated Age/sex: 15+ Male 2015 2,989
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 9,661
CARE_NEW Sum of Age/sex disaggregates 2015 9,661
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 9,661
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 57
CARE_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services 2015 57
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 57
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 57
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 57
CARE_SITE_den Sum of Denominator Site Support Type disaggregates 2015 57
FN_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 51
FN_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 57
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 51
FN_SITE Sum of Numerator Support Type disaggregates 2015 51
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 57
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 57
FN_THER Age: <1 2015 27
FN_THER Age: 1-4 2015 181
FN_THER Age: 15-17 2015 170
FN_THER Age: 18+ 2015 7,447
FN_THER Age: 5-14 2015 565
FN_THER Aggregated Age: <18 2015 943
FN_THER Aggregated Age: 18+ 2015 7,447
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 8,390
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 11,186
FN_THER Sum of Age disaggregates 2015 8,390
FN_THER Sum of Aggregated Age disaggregates 2015 8,390
FPINT_SITE By site support type: Direct Service Delivery (DSD): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 44
FPINT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported HIV service delivery points 2015 57
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 44
FPINT_SITE Service delivery type: Clinical 2015 44
FPINT_SITE Sum of Numerator Site Support Type disaggregates 2015 44
FPINT_SITE Sum of Service Delivery Type disaggregates 2015 44
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2015 57
FPINT_SITE_den Sum of Denominator Site Support Type disaggregates 2015 57
HTS_TST Age/sex: 1-4 Female 2015 3,263
HTS_TST Age/sex: 1-4 Female 2015 3,263
HTS_TST Age/sex: 1-4 Male 2015 3,263
HTS_TST Age/sex: 1-4 Male 2015 3,263
HTS_TST Age/sex: 10-14 Female 2015 2,330
HTS_TST Age/sex: 10-14 Female 2015 2,330
HTS_TST Age/sex: 10-14 Male 2015 2,330
HTS_TST Age/sex: 10-14 Male 2015 2,330
HTS_TST Age/sex: 15-19 Female 2015 4,661
HTS_TST Age/sex: 15-19 Female 2015 4,661
HTS_TST Age/sex: 15-19 Male 2015 4,661
HTS_TST Age/sex: 15-19 Male 2015 4,661
HTS_TST Age/sex: 20-24 Female 2015 11,652
HTS_TST Age/sex: 20-24 Female 2015 11,652
HTS_TST Age/sex: 20-24 Male 2015 11,652
HTS_TST Age/sex: 20-24 Male 2015 11,652
HTS_TST Age/sex: 25-49 Female 2015 18,644
HTS_TST Age/sex: 25-49 Female 2015 18,644
HTS_TST Age/sex: 25-49 Male 2015 18,644
HTS_TST Age/sex: 25-49 Male 2015 18,644
HTS_TST Age/sex: 5-9 Female 2015 1,398
HTS_TST Age/sex: 5-9 Female 2015 1,398
HTS_TST Age/sex: 5-9 Male 2015 1,398
HTS_TST Age/sex: 5-9 Male 2015 1,398
HTS_TST Age/sex: 50+ Female 2015 4,662
HTS_TST Age/sex: 50+ Female 2015 4,662
HTS_TST Age/sex: 50+ Male 2015 4,661
HTS_TST Age/sex: 50+ Male 2015 4,661
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 6,991
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 6,991
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 39,619
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 39,618
HTS_TST Aggregated Age/sex: <15 Female 2015 6,991
HTS_TST Aggregated Age/sex: <15 Male 2015 6,991
HTS_TST Aggregated Age/sex: 15+ Female 2015 39,619
HTS_TST Aggregated Age/sex: 15+ Male 2015 39,618
HTS_TST By Test Result: Negative 2015 89,490
HTS_TST By Test Result: Negative 2015 89,490
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 93,219
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 93,219
HTS_TST Sum of Age/Sex disaggregates 2015 93,219
HTS_TST Sum of Age/Sex disaggregates 2015 93,219
HTS_TST Sum of Aggregated Age/Sex <15 2015 13,982
HTS_TST Sum of Aggregated Age/Sex <15 2015 13,982
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 79,237
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 79,237
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 93,219
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 93,219
HTS_TST Sum of Test Result disaggregates 2015 93,219
HTS_TST Sum of Test Result disaggregates 2015 93,219
HTS_TST_POS By Test Result: Positive 2015 3,729
HTS_TST_POS By Test Result: Positive 2015 3,729
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 57
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 57
LAB_CAP Sum of Site Support Type disaggregates 2015 57
PMTCT_ARV Life-long ART (including Option B+) 2015 1,441
PMTCT_ARV Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 481
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 1,922
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,922
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 768
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 673
PMTCT_ARV Sum of New and Current disaggregates 2015 1,441
PMTCT_ARV Sum of Regimen Type disaggregates 2015 1,922
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 1,441
PMTCT_ARV_NGI Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 481
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 1,922
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,922
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 768
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 673
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 1,441
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 1,922
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 1,153
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 384
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 77
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 1,922
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 1,537
PMTCT_EID Sum of Infant Age disaggregates 2015 1,537
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 57
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 57
PMTCT_SITE Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 57
PMTCT_SITE Sum of Numerator Support Type disaggregates 2015 57
PMTCT_SITE Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 57
PMTCT_SITE_den Sum of Denominator Support Type disaggregates 2015 57
PMTCT_STAT By: Known positives at entry 2015 904
PMTCT_STAT By: Number of new positives identified 2015 1,018
PMTCT_STAT Number of new ANC and L&D clients 2015 19,142
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 19,142
PMTCT_STAT Sum of Positives Status disaggregates 2015 1,922
PMTCT_STAT_NGI By: Known positives at entry 2015 904
PMTCT_STAT_NGI By: Number of new positives identified 2015 1,018
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 19,142
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 19,142
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 1,922
QI_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 46
QI_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC 2015 57
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 46
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 46
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 57
QI_SITE_den Sum of Denominator Site Support Type disaggregates 2015 57
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 57
SITE_SUPP By program area/support type: Food and Nutrition Direct Service Delivery (DSD) 2015 57
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 57
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 57
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Direct Service Delivery (DSD) 2015 57
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 57
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 57
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 57
SITE_SUPP Number of unique sites supported by PEPFAR 2015 57
TB_ART Age: 0-4 2015 59
TB_ART Age: 15+ 2015 2,171
TB_ART Age: 5-14 2015 161
TB_ART Aggregated Age: <15 2015 220
TB_ART Aggregated Age: 15+ 2015 2,171
TB_ART Female 2015 1,100
TB_ART Known HIV-positive 2015 956
TB_ART Male 2015 1,291
TB_ART Newly tested 2015 1,435
TB_ART Sum of Aggregated Age disaggregates 2015 2,391
TB_ART Sum of Sex disaggregates 2015 2,391
TB_ART Sum of Test Status disaggregates 2015 2,391
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 2,657
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 2,391
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units 2015 57
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 57
TB_ARTSITE Sum of Numerator Site Support Type disaggregates 2015 57
TB_ARTSITE The number of PEPFAR-supported TB basic management units 2015 57
TB_ARTSITE The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 57
TB_ARTSITE_den Sum of Denominator Site Support Type disaggregates 2015 57
TB_SCREEN Age: <1 2015 161
TB_SCREEN Age: 1-4 2015 1,089
TB_SCREEN Age: 10-14 2015 1,480
TB_SCREEN Age: 15-19 2015 1,021
TB_SCREEN Age: 20-24 2015 3,403
TB_SCREEN Age: 25-49 2015 33,427
TB_SCREEN Age: 5-9 2015 1,922
TB_SCREEN Age: 50+ 2015 7,975
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 4,652
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 45,826
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 53,135
TB_SCREEN Sex: Female 2015 32,571
TB_SCREEN Sex: Male 2015 17,907
TB_SCREEN Sum of Age disaggregates 2015 5,673
TB_SCREEN Sum of Aggregated Age disaggregates 2015 50,478
TB_SCREEN Sum of Sex disaggregates 2015 50,478
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 50,478
TX_CURR Age/Sex: <1 Female 2015 82
TX_CURR Age/Sex: <1 Male 2015 82
TX_CURR Age/Sex: 1-4 Female 2015 553
TX_CURR Age/Sex: 1-4 Male 2015 553
TX_CURR Age/Sex: 15+ Female 2015 30,948
TX_CURR Age/Sex: 15+ Male 2015 16,664
TX_CURR Age/Sex: 5-14 Female 2015 1,725
TX_CURR Age/Sex: 5-14 Male 2015 1,725
TX_CURR Aggregated Age/Sex: <1 Female 2015 82
TX_CURR Aggregated Age/Sex: <1 Male 2015 82
TX_CURR Aggregated Age/Sex: <15 Female 2015 2,360
TX_CURR Aggregated Age/Sex: <15 Male 2015 2,360
TX_CURR Aggregated Age/Sex: 15+ Female 2015 30,948
TX_CURR Aggregated Age/Sex: 15+ Male 2015 16,664
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 52,332
TX_CURR Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 1
TX_CURR Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 1
TX_CURR Sum of age/sex disaggregates 2015 4,720
TX_CURR Sum of Aggregated Age/Sex <15 2015 4,720
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 47,612
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 52,332
TX_CURR_NGI Age/Sex: <1 Female 2015 82
TX_CURR_NGI Age/Sex: <1 Male 2015 82
TX_CURR_NGI Age/Sex: 1-4 Female 2015 553
TX_CURR_NGI Age/Sex: 1-4 Male 2015 553
TX_CURR_NGI Age/Sex: 15+ Female 2015 30,948
TX_CURR_NGI Age/Sex: 15+ Male 2015 16,664
TX_CURR_NGI Age/Sex: 5-14 Female 2015 1,725
TX_CURR_NGI Age/Sex: 5-14 Male 2015 1,725
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 82
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 82
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 2,360
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 2,360
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 30,948
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 16,664
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 52,332
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 52,332
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 4,720
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 47,612
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 52,332
TX_DIST Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District 2015 7
TX_DIST Total number of PEPFAR supported District Health Offices 2015 9
TX_NEW Aggregated Grouping by Age: <1 Male 2015 131
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 131
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 436
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 436
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 3,453
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 1,859
TX_NEW Breastfeeding status 2015 67
TX_NEW By Age/Sex: <1 Female 2015 131
TX_NEW By Age/Sex: <1 Male 2015 131
TX_NEW By Age/Sex: 1-4 Female 2015 74
TX_NEW By Age/Sex: 1-4 Male 2015 74
TX_NEW By Age/Sex: 10-14 Female 2015 101
TX_NEW By Age/Sex: 10-14 Male 2015 100
TX_NEW By Age/Sex: 15-19 Female 2015 73
TX_NEW By Age/Sex: 15-19 Male 2015 46
TX_NEW By Age/Sex: 20-24 Female 2015 302
TX_NEW By Age/Sex: 20-24 Male 2015 85
TX_NEW By Age/Sex: 25-49 Female 2015 2,582
TX_NEW By Age/Sex: 25-49 Male 2015 1,283
TX_NEW By Age/Sex: 5-9 Female 2015 130
TX_NEW By Age/Sex: 5-9 Male 2015 131
TX_NEW By Age/Sex: 50+ Female 2015 496
TX_NEW By Age/Sex: 50+ Male 2015 445
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 6,184
TX_NEW Pregnancy status 2015 605
TX_NEW Sum of Age/Sex disaggregates 2015 6,184
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 6,184
TX_RET Age: 0-4 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 132
TX_RET Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 4,836
TX_RET Age: 5-14 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 359
TX_RET Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 491
TX_RET Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 4,836
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 5,327
TX_RET Pregnancy and breastfeeding status (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 1,201
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 6,267
TX_RET_den Age: 0-4 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 155
TX_RET_den Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 5,690
TX_RET_den Age: 5-14 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 422
TX_RET_den Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 578
TX_RET_den Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 5,690
TX_RET_den Pregnancy and breastfeeding status (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 1,413
TX_SITE By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 40
TX_SITE By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites 2015 57
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 40
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 40
TX_SITE Total number of PEPFAR-supported ART sites 2015 57
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 57
Cross Cutting Budget Categories and Known Amounts Total: $2,599,961
Human Resources for Health $2,261,693
Gender: Gender Based Violence (GBV) $169,134
Post GBV Care
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $169,134
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Safe Motherhood
Tuberculosis
Family Planning